Skip to content

Economic and Social Empowerment To Increase Upwards Mobility Among Women

ESTIMA: Economic and Social Empowerment To Increase Upwards Mobility Among Women

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02266108
Acronym
ESTIMA
Enrollment
151
Registered
2014-10-16
Start date
2014-08-01
Completion date
2018-09-30
Last updated
2019-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Human Immunodeficiency Virus, Sexually Transmitted Infections

Keywords

Sexually Transmitted Infections, Female Sex Workers

Brief summary

The proposed research aims to pilot a multi-strategy structural intervention combining community mobilization to promote gender equity alongside an economic intervention (microfinance and business training) in order to reduce gender-based violence and HIV risk among female sex workers (FSW) in Tijuana, Mexico. The program will be called ESTIMA: Economic and Social Empowerment To Increase Upwards Mobility Among Women. The evaluation will employ a randomized controlled design, recruiting FSW (n=120, 60 in each arm) who will be randomized to: 1) ESTIMA (gender equity/community mobilization program and economic intervention) or 2) a wait-list control group. For this preliminary work, at 12 months follow-up, we hypothesize that compared to control participants, intervention participants will have: 1) significantly greater economic security (e.g. decreased debt, increased income, decreased number of sex trades) and 2) significantly greater perceived collective power (i.e. collective efficacy) to address gendered power imbalances within social structures and the community. The long-term goal of this program, upon future refinement and large scale implementation, is to reduce HIV risk behaviors, STI/HIV, GBV, and ultimately, alleviate a multitude of health burdens among women. Furthermore, we expect that such work will highlight the need for HIV prevention initiatives in Mexico, and elsewhere, to more broadly consider women's 'life contexts' - addressing economic and social burdens in women's lives, to reduce the burden of poverty, gender, and HIV, as well as the intersection of these among women.

Detailed description

The ESTIMA program will consist of the 1) Via microfinance program, which includes providing women with monetary loans as a group (approximately 10 women, with repayment as a group) and training them to initiate a business or other investment endeavor, and 2) gender equity community mobilization, which involves initiating groups of women (i.e. collectives) and engaging in social action within the community, with a focus on addressing issues relevant to gender inequities and women's economic mobility and power (such as client or police violence/harassment). Like the IMAGE program in South Africa, community mobilization will be incorporated into the Via microfinance trainings. Priorities of mobilization efforts will be identified by the ESTIMA collectives, and facilitated by the election of collective leaders. As part of the microfinance efforts, women will be provided with a loan of up to $200 each and will support each other by agreeing to all be responsible to repay the loan as a group. While the amount is small, women can take out more money with subsequent loans to help them support the business. The outcome evaluation of ESTIMA will employ a randomized controlled design. From the parent study (Dr. Brouwer, PI;R01 DA028692), we will recruit at least 120 participants in expectation to afford a final sample size of at least 48 in each group (using a conservative estimate of 80% retention). Eligible and willing participants will be randomized to treatment assignment (ESTIMA or wait-list control group) using a randomizer software package, after baseline data collection for the proposed research. The wait-list control group will be provided with referrals to local FSW support organizations, as the standard of care, and will receive ESTIMA subsequent to the 12 month follow-up data collection. ESTIMA will involve groups of approximately 10 women each; groups will initiate once sufficient numbers are enrolled (i.e. groups will be staggered in initiation of the ESTIMA program). Data collection will include a behavioral survey as well as HIV/STI testing. This combined program addresses economic vulnerability while also supporting women via community mobilization to address challenging social conditions at work, in the community, and at home. This work affords an opportunity to evaluate the efficacy of a microfinance-based initiative to improve health outcomes among an economically vulnerable population of women, many who have been trafficked into sex work, and who face dire economic circumstances to support their families and children. The randomized controlled evaluation design will be among the first implemented among sex workers and among the few implemented globally to evaluate a microfinance-based program in terms of improving health outcomes. Such a robust design will be key to providing evidence needed regarding the efficacy of the ESTIMA program, and implications of the utility of microfinance as a means of HIV prevention among this population.

Interventions

BEHAVIORALESTIMA Intervention

This study involves the evaluation of ESTIMA, a microfinance and gender equity intervention among women working as sex workers in Tijuana, Mexico.

Sponsors

University of California, San Diego
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Biologically female, * At least 18 years old, * Ability to Speak English or Spanish * Report having exchanged sex for money, goods, shelter or drugs within the last month, * Live in Tijuana or its suburbs and have no plans to permanently move over the next 18 months * Willing and able to provide informed consent * Agree to receive antibiotic treatment for Chlamydia, gonorrhea and syphilis if they test positive

Exclusion criteria

* Not be a part of a recent behavioral intervention.

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Decreased Economic Vulnerability12 monthsEconomic vulnerability was measured by asking women about several financial challenges creating urgency in their work. We also measured income.
Number of Participants With Increased Collective Efficacy12 monthsimproved reported support from other women; increased sense of unity within group, increased sense of belonging
Decreased Sexually Transmitted Infections6 monthsdecreased reported Sexually Transmitted Infections

Countries

Mexico

Participant flow

Participants by arm

ArmCount
ESTIMA Intervention
This group is randomized to receive the ESTIMA intervention and will be followed for 12 months for follow-up. ESTIMA Intervention: This study involves the evaluation of ESTIMA, a microfinance and gender equity intervention among women working as sex workers in Tijuana, Mexico.
80
Wait-list Control
This group will receive standard of care (education as well as referrals to testing and treatment). After 12 months of follow-up, this group will receive the ESTIMA intervention. ESTIMA Intervention: This study involves the evaluation of ESTIMA, a microfinance and gender equity intervention among women working as sex workers in Tijuana, Mexico.
71
Total151

Baseline characteristics

CharacteristicWait-list ControlTotalESTIMA Intervention
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
71 Participants151 Participants80 Participants
Age, Continuous37 years
STANDARD_DEVIATION 11
37 years
STANDARD_DEVIATION 11
37 years
STANDARD_DEVIATION 12
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
1 Participants3 Participants2 Participants
Race (NIH/OMB)
More than one race
31 Participants60 Participants29 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
2 Participants3 Participants1 Participants
Race (NIH/OMB)
Unknown or Not Reported
14 Participants42 Participants28 Participants
Race (NIH/OMB)
White
23 Participants43 Participants20 Participants
Region of Enrollment
Mexico
71 Participants151 Participants80 Participants
Sex: Female, Male
Female
71 Participants151 Participants80 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 800 / 71
other
Total, other adverse events
0 / 800 / 71
serious
Total, serious adverse events
0 / 800 / 71

Outcome results

Primary

Decreased Sexually Transmitted Infections

decreased reported Sexually Transmitted Infections

Time frame: 6 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
ESTIMA InterventionDecreased Sexually Transmitted Infections26 Participants
Wait-list ControlDecreased Sexually Transmitted Infections30 Participants
Primary

Number of Participants With Decreased Economic Vulnerability

Economic vulnerability was measured by asking women about several financial challenges creating urgency in their work. We also measured income.

Time frame: 12 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
ESTIMA InterventionNumber of Participants With Decreased Economic Vulnerability51 Participants
Wait-list ControlNumber of Participants With Decreased Economic Vulnerability37 Participants
Primary

Number of Participants With Increased Collective Efficacy

improved reported support from other women; increased sense of unity within group, increased sense of belonging

Time frame: 12 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
ESTIMA InterventionNumber of Participants With Increased Collective Efficacy42 Participants
Wait-list ControlNumber of Participants With Increased Collective Efficacy30 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026